PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
18.13%
Positive growth while CRON.TO shows revenue decline. John Neff would investigate competitive advantages.
-2.23%
Both companies reducing costs. Martin Whitman would check industry efficiency trends.
126.49%
Gross profit growth below 50% of CRON.TO's 256.46%. Michael Burry would check for structural issues.
91.73%
Margin expansion below 50% of CRON.TO's 267.31%. Michael Burry would check for structural issues.
119.27%
R&D growth while CRON.TO reduces spending. John Neff would investigate strategic advantage.
50.66%
G&A growth above 1.5x CRON.TO's 18.25%. Michael Burry would check for operational inefficiency.
-5.36%
Both companies reducing marketing spend. Martin Whitman would check industry trends.
-101.65%
Other expenses reduction while CRON.TO shows 522.55% growth. Joel Greenblatt would examine efficiency.
49.22%
Operating expenses growth while CRON.TO reduces costs. John Neff would investigate differences.
15.49%
Total costs growth while CRON.TO reduces costs. John Neff would investigate differences.
-12.53%
Interest expense reduction while CRON.TO shows 29128.57% growth. Joel Greenblatt would examine advantage.
144.30%
D&A growth while CRON.TO reduces D&A. John Neff would investigate differences.
-43.69%
EBITDA decline while CRON.TO shows 81.50% growth. Joel Greenblatt would examine position.
-361.27%
Both companies show margin pressure. Martin Whitman would check industry conditions.
7.01%
Operating income growth below 50% of CRON.TO's 81.88%. Michael Burry would check for structural issues.
21.28%
Operating margin growth below 50% of CRON.TO's 81.33%. Michael Burry would check for structural issues.
-119.25%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-177.82%
Pre-tax income decline while CRON.TO shows 75.93% growth. Joel Greenblatt would examine position.
-165.87%
Pre-tax margin decline while CRON.TO shows 75.20% growth. Joel Greenblatt would examine position.
0.38%
Tax expense growth less than half of CRON.TO's 233.09%. David Dodd would verify if advantage is sustainable.
-223.94%
Net income decline while CRON.TO shows 75.57% growth. Joel Greenblatt would examine position.
-204.92%
Net margin decline while CRON.TO shows 74.82% growth. Joel Greenblatt would examine position.
-151.50%
EPS decline while CRON.TO shows 75.81% growth. Joel Greenblatt would examine position.
-151.50%
Diluted EPS decline while CRON.TO shows 75.81% growth. Joel Greenblatt would examine position.
0.66%
Share count reduction below 50% of CRON.TO's 0.68%. Michael Burry would check for concerns.
0.66%
Diluted share reduction below 50% of CRON.TO's 0.21%. Michael Burry would check for concerns.